Scispace (Formerly Typeset)
  1. Home
  2. Journals
  3. Drug and Alcohol Dependence
  4. 2009
  1. Home
  2. Journals
  3. Drug and Alcohol Dependence
  4. 2009
Showing papers in "Drug and Alcohol Dependence in 2009"
Journal Article•10.1016/J.DRUGALCDEP.2008.08.001•
Caffeinated energy drinks--a growing problem.

[...]

Chad J. Reissig1, Eric C. Strain1, Roland R. Griffiths1•
Johns Hopkins University School of Medicine1
01 Jan 2009-Drug and Alcohol Dependence
TL;DR: Several studies suggest that energy drinks may serve as a gateway to other forms of drug dependence, and regulatory implications concerning labeling and advertising, and the clinical implications for children and adolescents are discussed.

1,026 citations

Journal Article•10.1016/J.DRUGALCDEP.2008.08.003•
Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 months later

[...]

Bertha K. Madras1, Wilson M. Compton2, Deepa Avula3, Tom Stegbauer3, Jack B. Stein3, H. Westley Clark3 •
Harvard University1, National Institute on Drug Abuse2, Substance Abuse and Mental Health Services Administration3
01 Jan 2009-Drug and Alcohol Dependence
TL;DR: SBIRT was feasible to implement and the self-reported patient status at 6 months indicated significant improvements over baseline, for illicit drug use and heavy alcohol use, with functional domains improved, across a range of health care settings and a rangeof patients.

681 citations

Journal Article•10.1016/J.DRUGALCDEP.2008.12.019•
Does delay discounting play an etiological role in smoking or is it a consequence of smoking

[...]

Janet Audrain-McGovern1, Daniel Rodriguez1, Leonard H. Epstein2, Jocelyn Cuevas1, Kelli Rodgers1, E. Paul Wileyto1 •
University of Pennsylvania1, University at Buffalo2
01 Aug 2009-Drug and Alcohol Dependence
TL;DR: Delayed discounting may provide a variable by which to screen for smoking vulnerability and help identify subgroups to target for more intensive smoking prevention efforts that include novel behavioral components directed toward aspects of impulsivity.

419 citations

Journal Article•10.1016/J.DRUGALCDEP.2009.05.021•
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.

[...]

Louisa Degenhardt1, Deborah Randall1, Wayne Hall2, Matthew Law3, Tony Butler4, Lucy Burns1 •
National Drug and Alcohol Research Centre1, University of Queensland2, University of New South Wales3, Curtin University4
01 Nov 2009-Drug and Alcohol Dependence
TL;DR: Mortality among treatment-seeking opioid-dependent persons is dynamic across time, patient and treatment variables, and despite periods of elevated risk, this large-scale provision of pharmacotherapy is estimated to have resulted in significant reductions in mortality.

358 citations

Journal Article•10.1016/J.DRUGALCDEP.2008.06.014•
Transitions from first substance use to substance use disorders in adolescence: Is early onset associated with a rapid escalation?

[...]

Silke Behrendt1, Hans-Ulrich Wittchen2, Michael Höfler2, Roselind Lieb2, Katja Beesdo1 •
Dresden University of Technology1, Max Planck Society2
01 Jan 2009-Drug and Alcohol Dependence
TL;DR: Higher age of onset of any SU is found to be associated with faster transitions to SUD, except for cannabis dependence, which may have important implications for designing early and targeted interventions to prevent disorder progression.

357 citations

Journal Article•10.1016/J.DRUGALCDEP.2009.01.012•
Developmental epidemiology of drug use and abuse in adolescence and young adulthood: Evidence of generalized risk.

[...]

Rohan H. C. Palmer, Susan E. Young, Christian J. Hopfer1, Robin P. Corley, Michael C. Stallings, Thomas J. Crowley1, John K. Hewitt •
University of Colorado Denver1
01 Jun 2009-Drug and Alcohol Dependence
TL;DR: Data on developmental trends of alcohol, tobacco, and marijuana use, abuse and dependence assessed during adolescence and young adulthood in a community-based Colorado twin sample of 1733 respondents is presented.

291 citations

Journal Article•10.1016/J.DRUGALCDEP.2009.01.007•
Subtypes of nonmedical prescription drug misuse

[...]

Sean Esteban McCabe1, Carol J. Boyd1, Christian J. Teter2, Christian J. Teter3, Christian J. Teter1 •
University of Michigan1, McLean Hospital2, Northeastern University3
01 Jun 2009-Drug and Alcohol Dependence
TL;DR: The findings indicate subtypes should be considered when examining nonmedical prescription drug misuse, especially for pain medication, and the odds of substance use and abuse were generally lower among self-treatment subtypes than other subtypes.

278 citations

Journal Article•10.1016/J.DRUGALCDEP.2009.06.015•
Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide Survey

[...]

Amy Nunn1, Nickolas Zaller1, Nickolas Zaller2, Samuel Dickman1, Catherine Trimbur3, Ank E. Nijhawan2, Ank E. Nijhawan1, Josiah D. Rich2, Josiah D. Rich1 •
Brown University1, Miriam Hospital2, University of Rochester3
01 Nov 2009-Drug and Alcohol Dependence
TL;DR: Despite demonstrated social, medical, and economic benefits of providing ORT to inmates during incarceration and linkage to ORT upon release, many prison systems nationwide still do not offer pharmacological treatment for opiate addiction or referrals to community buprenorphine providers.

254 citations

Journal Article•10.1016/J.DRUGALCDEP.2008.07.018•
Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty

[...]

Tami L. Mark, Cheryl A. Kassed, Rita Vandivort-Warren1, Katharine R. Levit, Henry R. Kranzler2 •
Substance Abuse and Mental Health Services Administration1, University of Connecticut2
01 Jan 2009-Drug and Alcohol Dependence
TL;DR: While acamprosate and buprenorphine grew rapidly after market entry, overall substance abuse retail medication sales remain small relative to the size of the population that could benefit from treatment and relative to sales for other medications, such as antidepressants.

234 citations

Journal Article•10.1016/J.DRUGALCDEP.2009.04.015•
Modafinil for the treatment of cocaine dependence.

[...]

Ann L. Anderson1, Malcolm S. Reid2, Shou Hua Li1, Tyson H. Holmes3, Lynn Shemanski, April Slee, Edwina V. Smith1, Roberta Kahn1, Nora Chiang1, Frank Vocci1, Domenic A. Ciraulo4, Charles A. Dackis5, John D. Roache6, Ihsan M. Salloum7, Eugene Somoza, Harold C. Urschel, Ahmed Elkashef1 •
National Institutes of Health1, New York University2, Stanford University3, Boston University4, University of Pennsylvania5, University of Texas at Austin6, University of Miami7
01 Sep 2009-Drug and Alcohol Dependence
TL;DR: Data suggest that modafinil, in combination with individual behavioral therapy, was effective for increasing cocaine non-use days in participants without co-morbid alcohol dependence, and in reducing cocaine craving.

233 citations

Journal Article•10.1016/J.DRUGALCDEP.2008.08.006•
Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial

[...]

Stephen Magura1, Joshua D. Lee2, Jason Hershberger3, Herman Joseph4, Lisa A. Marsch4, Carol Shropshire, Andrew Rosenblum4 •
Western Michigan University1, New York University2, New York City Department of Health and Mental Hygiene3, National Development and Research Institutes4
01 Jan 2009-Drug and Alcohol Dependence
TL;DR: After initiating opioid agonist treatment in jail, continuing buprenorphine maintenance in the community appears to be more acceptable to offenders than continuing methadone maintenance.
Journal Article•10.1016/J.DRUGALCDEP.2009.01.015•
The Adolescent Substance Abuse Prevention Study: A randomized field trial of a universal substance abuse prevention program

[...]

Zili Sloboda1, Richard C. Stephens1, Peggy C. Stephens1, Scott F. Grey2, Brent Teasdale3, Richard D. Hawthorne, Joseph Williams1, Jesse F. Marquette4 •
University of Akron1, Case Western Reserve University2, Georgia State University3, University of Central Florida4
01 Jun 2009-Drug and Alcohol Dependence
TL;DR: The negative impact of the program on baseline nonusers of alcohol and tobacco indicate that TCYL should not be delivered as a universal prevention intervention, and the finding of a beneficial effect for baseline marijuana users further supports this conclusion.
Journal Article•10.1016/J.DRUGALCDEP.2009.04.003•
Principles of laboratory assessment of drug abuse liability and implications for clinical development.

[...]

Lawrence P. Carter1, Roland R. Griffiths2•
University of Arkansas for Medical Sciences1, Johns Hopkins University2
01 Dec 2009-Drug and Alcohol Dependence
TL;DR: The current "gold standard" methodologies that are used for laboratory assessments of abuse liability in non-human and human subjects are described and particular emphasis is given to procedures such as non- human drug discrimination, self-administration, and physical dependence testing, and human dose-effect abuse liability studies that are commonly used in regulatory submissions to governmental agencies.
Journal Article•10.1016/J.DRUGALCDEP.2009.01.023•
Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts.

[...]

Ziva D. Cooper1, Margaret Haney1•
Columbia University1
01 Aug 2009-Drug and Alcohol Dependence
TL;DR: It is demonstrated that smoking marijuana in a tobacco leaf may increase the risks of marijuana use by enhancing carbon monoxide exposure and increasing heart rate compared to joints, and these effects were more pronounced in women compared to men.
Journal Article•10.1016/J.DRUGALCDEP.2008.08.007•
Tobacco and cannabis co-occurrence: does route of administration matter?

[...]

Arpana Agrawal1, Michael T. Lynskey1•
Washington University in St. Louis1
01 Jan 2009-Drug and Alcohol Dependence
TL;DR: Route of administration may play an important role in the observed association between tobacco and cannabis use, and may represent a physiological adaptation of the aero-respiratory system and/or index social and cultural influences surrounding the use of smoked versus smokeless forms of tobacco.
Journal Article•10.1016/J.DRUGALCDEP.2009.01.019•
Pathways between nonmedical opioid use/dependence and psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions

[...]

Silvia S. Martins1, Katherine M. Keyes2, Carla L. Storr3, Carla L. Storr1, Hong Zhu1, Howard D. Chilcoat1, Howard D. Chilcoat4 •
Johns Hopkins University1, Columbia University2, University of Maryland, College Park3, Research Triangle Park4
01 Jul 2009-Drug and Alcohol Dependence
TL;DR: A general vulnerability to nonmedical opioid use and major psychopathologies is supported, as well as evidence for a 'self-medication' model for dependence resulting from non medical opioid use with bipolar disorder and generalized anxiety disorder.
Journal Article•10.1016/J.DRUGALCDEP.2008.09.015•
Enduring effects of a computer-assisted training program for cognitive behavioral therapy: A 6-month follow-up of CBT4CBT

[...]

Kathleen M. Carroll1, Samuel A. Ball1, Steve Martino1, Charla Nich1, Theresa Babuscio1, Bruce J. Rounsaville1 •
Yale University1
01 Feb 2009-Drug and Alcohol Dependence
TL;DR: The durability of the CBT4CBT effect remained even after controlling for treatment retention, treatment substance use outcomes, and exposure to other treatment during the follow-up period, suggesting both short-term and enduring effects on drug use.
Journal Article•10.1016/J.DRUGALCDEP.2009.06.019•
Altered Affective Response in Marijuana Smokers: An FMRI Study

[...]

Staci A. Gruber1, Jadwiga Rogowska2, Jadwiga Rogowska1, Deborah A. Yurgelun-Todd3•
McLean Hospital1, Harvard University2, University of Utah3
01 Nov 2009-Drug and Alcohol Dependence
TL;DR: Differences in affective processing in chronic smokers are suggested, even when stimuli are presented below the level of conscious processing, and underscore the likelihood that marijuana smokers process emotional information differently from those who do not smoke, which may result in negative consequences.
Journal Article•10.1016/J.DRUGALCDEP.2009.07.001•
Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument.

[...]

D. Andrew Tompkins1, George E. Bigelow1, Joseph A. Harrison1, Rolley E. Johnson1, Paul J. Fudala, Eric C. Strain1 •
Johns Hopkins University School of Medicine1
01 Nov 2009-Drug and Alcohol Dependence
TL;DR: The COWS was validated in comparison to the validated Clinical Institute Narcotic Assessment (CINA) scale, indicating good internal consistency (reliability) and certain VAS items are all valid measurement tools for acute opiate withdrawal.
Journal Article•10.1016/J.DRUGALCDEP.2009.03.021•
Opioid use behaviors, mental health and pain--development of a typology of chronic pain patients.

[...]

Caleb J. Banta-Green1, Joseph O. Merrill1, Suzanne R. Doyle1, Denise M. Boudreau2, Donald A. Calsyn1 •
University of Washington1, Group Health Cooperative2
01 Sep 2009-Drug and Alcohol Dependence
TL;DR: Three distinct types of patient classes are described as well as data elements that could help identify the two atypical types and prescribed average daily dose of opioids was three times higher for those in the twoatypical groups and was strongly associated with class membership after adjusting for other variables.
Journal Article•10.1016/J.DRUGALCDEP.2008.07.010•
Factors associated with substance use during pregnancy: results from a national sample.

[...]

Jennifer R. Havens1, Leigh Ann Simmons1, Lisa M. Shannon1, Wendy Hansen1•
University of Kentucky1
01 Jan 2009-Drug and Alcohol Dependence
TL;DR: Although the prevalence of substance use among pregnant women was significantly lower than non-pregnant women, some groups of women remain vulnerable to continued use, including those who are unemployed, unmarried, and experiencing possible current psychopathology.
Journal Article•10.1016/J.DRUGALCDEP.2008.08.010•
Concurrent anxiety and substance use disorders among outpatients with major depression: Clinical features and effect on treatment outcome

[...]

Robert H Howland1, A. John Rush2, Stephen R. Wisniewski1, Madhukar H. Trivedi2, Diane Warden2, Maurizio Fava3, Lori L. Davis4, Goundappa K. Balasubramani1, Patrick J. McGrath5, Susan Berman1 •
University of Pittsburgh1, University of Texas Southwestern Medical Center2, Harvard University3, University of Alabama at Birmingham4, Columbia University5
01 Jan 2009-Drug and Alcohol Dependence
TL;DR: Comorbid anxiety and/or substance use disorder are clinically identifiable, and their presence may define distinct MDD subgroups that have more problems and worse pharmacological treatment outcomes.
Journal Article•10.1016/J.DRUGALCDEP.2008.10.009•
The role of cannabis use within a dimensional approach to cannabis use disorders.

[...]

Wilson M. Compton1, Tulshi D. Saha2, Kevin P. Conway1, Bridget F. Grant2•
National Institute on Drug Abuse1, National Institutes of Health2
01 Mar 2009-Drug and Alcohol Dependence
TL;DR: Factor and IRT analyses disprove the validity of the DSM-IV abuse and dependence distinction: A single dimension represented the criteria rather than the two implied by the separate abuse/dependence categories.
Journal Article•10.1016/J.DRUGALCDEP.2009.03.009•
Daily ratings measures of alcohol craving during an inpatient stay define subtypes of alcohol addiction that predict subsequent risk for resumption of drinking.

[...]

David W. Oslin1, Mark S. Cary1, Valarie Slaymaker1, Carol Colleran1, Frederic C. Blow1 •
University of Pennsylvania1
01 Aug 2009-Drug and Alcohol Dependence
TL;DR: It is suggested that non-cue induced alcohol craving may define a subtype of alcohol dependence that is less responsive to treatment and may explain heterogeneity in treatment outcomes.
Journal Article•10.1016/J.DRUGALCDEP.2009.02.008•
Features of Men with Anabolic-Androgenic Steroid Dependence: A Comparison With Nondependent AAS Users and With AAS Nonusers

[...]

Gen Kanayama1, James I. Hudson1, Harrison G. Pope1•
Harvard University1
01 Jun 2009-Drug and Alcohol Dependence
TL;DR: Men with AAS dependence showed a particularly strong association with opioid dependence - an observation that recalls recent animal data suggesting similarities in AAS and opioid brain reward mechanisms.
Journal Article•10.1016/J.DRUGALCDEP.2009.03.017•
A prospective study of familial conflict, psychological stress, and the development of substance use disorders in adolescence

[...]

Margie R. Skeer1, Marie C. McCormick1, Sharon-Lise T. Normand1, Stephen L. Buka2, Stephen E. Gilman1 •
Harvard University1, Brown University2
01 Sep 2009-Drug and Alcohol Dependence
TL;DR: Exposure to familial conflict early in life increases the risk of substance use disorders during late adolescence and emerging adulthood, due partly to higher levels of externalizing problems, but not internalizing problems.
Journal Article•10.1016/J.DRUGALCDEP.2009.04.012•
Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): Differences in characteristics and misuse

[...]

Lawrence P. Carter1, Daniel Pardi, Jane Gorsline2, Roland R. Griffiths3•
University of Arkansas for Medical Sciences1, AmeriCorps VISTA2, Johns Hopkins University3
01 Sep 2009-Drug and Alcohol Dependence
TL;DR: Differences in the accessibility, purity, dosing, and misuse of illicit GHB and sodium oxybate suggest that risks associated with illicit Ghanaian gamma-hydroxybutyrate are greater than those associated with the pharmaceutical product sodium oxy bate.
Journal Article•10.1016/J.DRUGALCDEP.2008.09.012•
Neighborhood smoking norms modify the relation between collective efficacy and smoking behavior

[...]

Jennifer Ahern1, Jennifer Ahern2, Jennifer Ahern3, Sandro Galea3, Sandro Galea4, Sandro Galea1, Alan Hubbard2, S. Leonard Syme2 •
New York Academy of Medicine1, University of California, Berkeley2, University of Michigan3, Columbia University4
01 Feb 2009-Drug and Alcohol Dependence
TL;DR: Feature of the neighborhood social environment may need to be considered in combinations to understand their role in shaping health and health behavior.
Journal Article•10.1016/J.DRUGALCDEP.2008.11.011•
Modeling risk factors for nicotine and other drug abuse in the preclinical laboratory.

[...]

Marilyn E. Carroll1, Justin J. Anker1, Jennifer L. Perry•
University of Minnesota1
01 Oct 2009-Drug and Alcohol Dependence
TL;DR: Factors that preclinical research has determined are strong and translatable predictors of nicotine and other drug abuse over critical transition phases of addiction that are difficult to examine prospectively in humans are discussed.
Journal Article•10.1016/J.DRUGALCDEP.2009.05.017•
Racial/ethnic differences in correlates of prescription drug misuse among young adults.

[...]

Zaje A. T. Harrell1, Clifford L. Broman1•
Michigan State University1
01 Oct 2009-Drug and Alcohol Dependence
TL;DR: There are unique racial/ethnic profiles for substance use risk behaviors in adolescence and being younger, having less education, as well as alcohol use; marijuana use, inhalant use, and delinquent behavior during adolescence were associated with prescription drug misuse.
...

Tools

SciSpace AgentBiomedical AgentSciSpace RecruitSciSpace for EnterpriseAgent GalleryChat with PDFLiterature ReviewAI WriterFind TopicsParaphraserCitation GeneratorExtract DataAI DetectorCitation Booster

Learn

ResourcesLive Workshops

SciSpace

CareersSupportBrowse PapersPricingSciSpace Affiliate ProgramCancellation & Refund PolicyTermsPrivacyData Sources

Directories

PapersTopicsJournalsAuthorsConferencesInstitutionsCitation StylesWriting templates

Extension & Apps

SciSpace Chrome ExtensionSciSpace Mobile App

Contact

support@scispace.com
SciSpace

© 2026 | PubGenius Inc. | Suite # 217 691 S Milpitas Blvd Milpitas CA 95035, USA

soc2
Secured by Delve